These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3455634)

  • 21. [Pathological analysis of renal osteodystrophy in 194 cases].
    Yu YF
    Zhonghua Bing Li Xue Za Zhi; 1991 Dec; 20(4):280-3. PubMed ID: 1813163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy.
    Andress DL; Maloney NA; Coburn JW; Endres DB; Sherrard DJ
    J Clin Endocrinol Metab; 1987 Jul; 65(1):11-6. PubMed ID: 3584392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes of PTH, 1,25(OH)2D3 and biochemistry in renal osteodystrophy].
    Jia JK; Lou DX; Zhu P
    Zhonghua Nei Ke Za Zhi; 1994 Jan; 33(1):33-6. PubMed ID: 8045186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone disease in renal failure. Clinical and histomorphometric studies.
    Nilsson P
    Scand J Urol Nephrol Suppl; 1984; 84():1-68. PubMed ID: 6393322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Micro-CT in the Assessment of Pediatric Renal Osteodystrophy by Bone Histomorphometry.
    Pereira RC; Bischoff DS; Yamaguchi D; Salusky IB; Wesseling-Perry K
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):481-7. PubMed ID: 26712809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term evolution of renal osteodystrophy after kidney transplantation: comparative study between intact PTH levels and bone biopsy.
    Gonzalez MT; Gonzalez C; Griñó JM; Castelao AM; Mariñoso ML; Serrano S; Bonnin R; Carreras L; Alsina J
    Transplant Proc; 1990 Aug; 22(4):1407-11. PubMed ID: 2389341
    [No Abstract]   [Full Text] [Related]  

  • 27. Association between fluoride, magnesium, aluminum and bone quality in renal osteodystrophy.
    Ng AH; Hercz G; Kandel R; Grynpas MD
    Bone; 2004 Jan; 34(1):216-24. PubMed ID: 14751580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal osteodystrophy in patients on hemodialysis for more than 10 years.
    Piraino BM; Rault R; Dominguez JH; Puschett JB
    Miner Electrolyte Metab; 1986; 12(5-6):390-6. PubMed ID: 3807834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aluminum: effects on bone and role in the pathogenesis of renal osteodystrophy.
    Goodman WG; Duarte ME
    Miner Electrolyte Metab; 1991; 17(4):221-32. PubMed ID: 1813784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal osteodystrophy in diabetic patients.
    Pei Y; Hercz G; Greenwood C; Segre G; Manuel A; Saiphoo C; Fenton S; Sherrard D
    Kidney Int; 1993 Jul; 44(1):159-64. PubMed ID: 8355457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling.
    Rojas E; Carlini RG; Clesca P; Arminio A; Suniaga O; De Elguezabal K; Weisinger JR; Hruska KA; Bellorin-Font E
    Kidney Int; 2003 May; 63(5):1915-23. PubMed ID: 12675872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of bone mineral density in patients on hemodialysis.
    Zayour D; Daouk M; Medawar W; Salamoun M; El-Hajj Fuleihan G
    Transplant Proc; 2004 Jun; 36(5):1297-301. PubMed ID: 15251316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
    Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationships between calcium and phosphorus homeostasis, parathyroid hormone levels, bone aluminum, and bone histomorphometry in patients on maintenance hemodialysis.
    Nilsson P; Melsen F; Malmaeus J; Danielson BG; Mosekilde L
    Bone; 1985; 6(1):21-7. PubMed ID: 2581596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased secondary hyperparathyroidism in diabetic patients receiving hemodialysis.
    Vincenti F; Hattner R; Amend WJ; Feduska NJ; Duca RM; Salvatierra O
    JAMA; 1981 Mar; 245(9):930-3. PubMed ID: 7007680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity.
    Wang M; Hercz G; Sherrard DJ; Maloney NA; Segre GV; Pei Y
    Am J Kidney Dis; 1995 Nov; 26(5):836-44. PubMed ID: 7485142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal osteodystrophy in pre-dialysis patients: ethnic difference?
    Shin SK; Kim DH; Kim HS; Shin KT; Ma KA; Kim SJ; Kwak YS; Ha SK; Sherrard DJ
    Perit Dial Int; 1999; 19 Suppl 2():S402-7. PubMed ID: 10406554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nutrition and renal osteodystrophy.
    Morii H; Nishizawa Y; Miki T; Ohnishi Y; Okui Y; Song G; Yukioka K; Kikunami K; Matsushita Y; Inoue T
    J Nutr Sci Vitaminol (Tokyo); 1985 Dec; 31 Suppl():S67-9. PubMed ID: 3837819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fractures and vertebral bone mineral density in patients with renal osteodystrophy.
    Piraino B; Chen T; Cooperstein L; Segre G; Puschett J
    Clin Nephrol; 1988 Aug; 30(2):57-62. PubMed ID: 3180516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG
    Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.